The pharmaceutical industry is increasingly recognizing the importance of adopting sustainable practices and materials to reduce its environmental impact. Loop's 100% recycled virgin quality PET can help support pharmaceutical companies with a sustainable packaging alternative and address the growing demand for environmentally responsible choices in the industry. The Infinite Loop™ technology upcycles the lowest quality PET and polyester fiber waste into 100% recycled virgin quality Loop™ PET resin. A recent test, executed by a worldwide leader in laboratory testing, confirms that Loop™ PET resin has successfully met the strict standards and requirements outlined by the EU Pharmacopeia (Ph.Eur. 3.1.15, Polyethylene Terephthalate for Containers for Preparations not for Parenteral Uses) and US Pharmacopeia (USP <661.1>, Plastic Materials of Construction) and is compliant for use in packaging applications in the pharmaceutical industry. Loop™ PET resin helps create circularity for low value waste while reducing greenhouse gas emissions and can save up to 360,000 tonnes of CO2 per year compared to virgin PET made from fossil fuels [1].
Bormioli Pharma and Loop Industries aim to introduce market-ready solutions for the global pharmaceutical industry and the two companies began to collaborate over a year ago in order to achieve this goal. Bormioli Pharma tested Loop™ PET resin in its packaging, commissioning to independent third parties’ additional analysis to verify extractables levels with different solutions, also taking in consideration the worst-case scenario. The results of these tests set a new benchmark for recycled plastic products within the pharmaceutical industry, as the bottles produced with Loop™ PET resin do not release any substance deemed of toxicological relevance [2].
